US Patent 7264922 Method of reducing complement - mediated disruption of cells
Patent 7264922 was granted and assigned to Wisconsin Alumni Research Foundation on September, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Rodney A. Welch0
Thomas E. Grys0
Wyndham W. Lathem0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+429 characters)
Article
Patent abstract
Disclosed is a pO157 plasmid-specified polypeptide found in E. coli EDL933 and other E. coli that binds to and cleaves C1-esterase inhibitor, and antibodies specific for the polypeptide. Also disclosed are methods employing the polypeptide for diagnosing enterohemorrhagic E. coli infection, identifying potential inhibitors of its activity, and reducing viscosity of material containing glycosylated polypeptides.
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07264922 Method of reducing complement - mediated disruption of cells US Patent 7264922 Method of reducing complement - mediated disruption of cells
Infobox
Patent Number
07264922
Patent Number
7264922
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07264922 Method of reducing complement - mediated disruption of cells
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07264922
Date of patent
September 4, 2007
Patent application number
11294087
Date Filed
December 5, 2005
Patent primary examiner
Find more entities like US Patent 7264922 Method of reducing complement - mediated disruption of cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
